VIEWPOINTS Dr. Richard Philipson, CMO at Calliditas Shares Results & Insights from P-III Study Evaluating TarpeyoBySenior EditorJanuary 9, 20230Comments
INSIGHTS+ J.P. Morgan Special: Dealmaker 2022 – Top M&A Deal of Roche (Part 01)BySenior EditorJanuary 5, 20230Comments
VIEWPOINTS Dr. Jeff Cleland, CEO & President at Ashvattha Therapeutics Shares his Views From First Patient Enrolled for the Treatment of AMD and DMEBySenior EditorJanuary 3, 20230Comments
EVENTS Need Coverage of 41st Annual J.P. Morgan Healthcare Conference 2023?BySenior EditorDecember 30, 20220Comments
INSIGHTS+ PharmaShots’ Key Highlights of Fourth Quarter 2022BySenior EditorDecember 29, 20220Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in November 2022BySenior EditorDecember 28, 20220Comments
VIEWPOINTS Brian Quigley, CEO at Qnovia Shares his Views on Raising Series A FundingBySenior EditorDecember 27, 20220Comments
